Skip to main content
SpringerLink
Log in

Rituximab use in children: risk of agammaglobulinaemia and infections

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ong MS, et al. New-onset Hypogammaglobulinemia and Infectious Complications Associated with Rituximab Use in Childhood-onset Rheumatic Diseases. Rheumatology : 30 Jul 2021. Available from: URL: http://doi.org/10.1093/rheumatology/keab626

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rituximab use in children: risk of agammaglobulinaemia and infections. Reactions Weekly 1868, 10 (2021). https://doi.org/10.1007/s40278-021-00467-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-00467-8

Search

Navigation